Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis.
Chronic migraine
Episodic migraine
Meta-analysis
TRPV1, polymorphism
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
10
05
2024
accepted:
29
07
2024
medline:
6
8
2024
pubmed:
6
8
2024
entrez:
6
8
2024
Statut:
aheadofprint
Résumé
To confirm a previously reported association of TRPV1 rs8065080 with the risk of transformation from episodic (EM) to chronic migraine (CM) and to extend knowledge about the role of other TRPV1 single nucleotide polymorphisms (SNPs), we first investigated the impact of three TRPV1 SNPs (rs8065080, rs222747 and rs222749) on the risk of migraine chronification in a case-control study. A systematic review and meta-analysis were then conducted to summarize the accumulated findings. Genotyping of the selected TRPV1 SNPs was performed using TaqMan real-time PCR in 167 EM and 182 CM participants. Crude and adjusted odds ratios with associated 95% confidence intervals were calculated in the log-additive, dominant, and recessive genetic models. A comprehensive literature search was performed in PubMed, Web of Knowledge, Cochrane Library, and OpenGrey until February 2024. In our case-control study, no association was found between TRPV1 SNPs and the risk of migraine chronification, both in the unadjusted logistic regression models and after adjustment for confounding clinical variables. The results of the meta-analysis with a total of 241 participants with EM and 223 with CM confirmed no association between TRPV1 SNPs and the risk of migraine chronification in any of the genetic models tested. The results of the present case-control study and meta-analysis exclude a major role of TRPV1 rs8065080, rs222747, and rs222749 as risk factors for migraine chronification. However, further research is needed to investigate the gene-gene and gene-environment interactions of TRPV1 SNPs on the risk of transformation from episodic to chronic migraine.
Identifiants
pubmed: 39105976
doi: 10.1007/s10072-024-07724-0
pii: 10.1007/s10072-024-07724-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19:109–117. https://doi.org/10.1038/s41582-022-00763-1
doi: 10.1038/s41582-022-00763-1
pubmed: 36693999
Demartini C, Francavilla M, Zanaboni AM, Facchetti S, De Icco R, Martinelli D, Allena M, Greco R, Tassorelli C (2023) Biomarkers of migraine: an Integrated evaluation of preclinical and clinical findings. Int J Mol Sci 24:5334. https://doi.org/10.3390/ijms24065334
doi: 10.3390/ijms24065334
pubmed: 36982428
pmcid: 10049673
Headache Classification Committee of the International Headache Society (IHS) (2018) The International classification of Headache disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202
doi: 10.1177/0333102417738202
Goadsby PJ, Evers S (2020) International classification of Headache disorders - ICHD-4 alpha. Cephalalgia 40(9):887–888. https://doi.org/10.1177/0333102420919098
doi: 10.1177/0333102420919098
pubmed: 32321289
Diener HC, Rizzoli P (2023) Chronic migraine and medication overuse. Handb Clin Neurol 198:187–200. https://doi.org/10.1016/B978-0-12-823356-6.00008-1
doi: 10.1016/B978-0-12-823356-6.00008-1
pubmed: 38043961
Rattanawong W, Rapoport A, Srikiatkhachorn A (2022) Neurobiology of migraine progression. Neurobiol Pain 12:100094. https://doi.org/10.1016/j.ynpai.2022.100094
doi: 10.1016/j.ynpai.2022.100094
pubmed: 35720639
pmcid: 9204797
Yeh PK, An YC, Hung KS, Yang FC (2024) Influences of genetic and environmental factors on chronic migraine: a narrative review. Curr Pain Headache Rep 28:169–180. https://doi.org/10.1007/s11916-024-01228-4
doi: 10.1007/s11916-024-01228-4
pubmed: 38363449
Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, Löf E, Brevig T, Cady R, Diener HC (2023) Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol 270:5692–5710. https://doi.org/10.1007/s00415-023-11880-2
doi: 10.1007/s00415-023-11880-2
pubmed: 37615752
pmcid: 10632231
Harder AVE, Terwindt GM, Nyholt DR, van den Maagdenberg AMJM (2023) Migraine genetics: Status and road forward. Cephalalgia 43:3331024221145962. https://doi.org/10.1177/03331024221145962
doi: 10.1177/03331024221145962
pubmed: 36759319
Spekker E, Körtési T, Vécsei L (2022) TRP channels: recent development in Translational Research and potential therapeutic targets in Migraine. Int J Mol Sci 24:700. https://doi.org/10.3390/ijms24010700
doi: 10.3390/ijms24010700
pubmed: 36614146
pmcid: 9820749
Rosenbaum T, Morales-Lázaro SL, Islas LD (2022) TRP channels: a journey towards a molecular understanding of pain. Nat Rev Neurosci 23:596–610. https://doi.org/10.1038/s41583-022-00611-7
doi: 10.1038/s41583-022-00611-7
pubmed: 35831443
Yakubova A, Davidyuk Y, Tohka J, Khayrutdinova O, Kudryavtsev I, Nurkhametova D, Kamshilin A, Giniatullin R, Rizvanov A (2021) Searching for predictors of Migraine Chronification: a pilot study of 1911A > G polymorphism of TRPV1 gene in episodic Versus Chronic Migraine. J Mol Neurosci 71:618–624. https://doi.org/10.1007/s12031-020-01683-9
doi: 10.1007/s12031-020-01683-9
pubmed: 32827294
Kuburas A, Russo AF (2023) Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain 24:34. https://doi.org/10.1186/s10194-023-01569-2
doi: 10.1186/s10194-023-01569-2
pubmed: 37009867
pmcid: 10069045
Cantero-Recasens G, Gonzalez JR, Fandos C, Duran-Tauleria E, Smit LA, Kauffmann F, Antó JM, Valverde MA (2010) Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma. J Biol Chem 285:27532–27535. https://doi.org/10.1074/jbc.C110.159491
doi: 10.1074/jbc.C110.159491
pubmed: 20639579
pmcid: 2934619
van Esch AA, Lamberts MP, te Morsche RH, van Oijen MG, Jansen JB, Drenth JP (2009) Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis. BMC Gastroenterol 9:97. https://doi.org/10.1186/1471-230X-9-97
doi: 10.1186/1471-230X-9-97
pubmed: 20034385
pmcid: 2813232
Valdes AM, De Wilde G, Doherty SA, Lories RJ, Vaughn FL, Laslett LL, Maciewicz RA, Soni A, Hart DJ, Zhang W, Muir KR, Dennison EM, Wheeler M, Leaverton P, Cooper C, Spector TD, Cicuttini FM, Chapman V, Jones G, Arden NK, Doherty M (2011) The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 70:1556–1561. https://doi.org/10.1136/ard.2010.148122
doi: 10.1136/ard.2010.148122
pubmed: 21616913
Binder A, May D, Baron R, Maier C, Tölle TR, Treede RD, Berthele A, Faltraco F, Flor H, Gierthmühlen J, Haenisch S, Huge V, Magerl W, Maihöfner C, Richter H, Rolke R, Scherens A, Uçeyler N, Ufer M, Wasner G, Zhu J, Cascorbi I (2011) Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS ONE 6:e17387. https://doi.org/10.1371/journal.pone.0017387
doi: 10.1371/journal.pone.0017387
pubmed: 21468319
pmcid: 3066165
Forstenpointner J, Förster M, May D, Hofschulte F, Cascorbi I, Wasner G, Gierthmühlen J, Baron R (2017) Short report: TRPV1-polymorphism 1911 A > G alters capsaicin-induced sensory changes in healthy subjects. PLoS ONE 12(8):e0183322. https://doi.org/10.1371/journal.pone.0183322
doi: 10.1371/journal.pone.0183322
pubmed: 28817717
pmcid: 5560710
Wang M, Gu Y, Meng S, Kang L, Yang J, Sun D, Liu Y, Wan Z, Shan Y, Xue D, Su C, Li S, Yan R, Liu Y, Zhao Y, Pan Y (2023) Association between TRP channels and glutamatergic synapse gene polymorphisms and migraine and the comorbidities anxiety and depression in a Chinese population. Front Genet 14:1158028. https://doi.org/10.3389/fgene.2023.1158028
doi: 10.3389/fgene.2023.1158028
pubmed: 37303955
pmcid: 10250607
Buttari F, Zagaglia S, Marciano L, Albanese M, Landi D, Nicoletti CG, Mercuri NB, Silvestrini M, Provinciali L, Marfia GA, Mori F, Centonze D (2017) TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 305:172–174. https://doi.org/10.1016/j.jneuroim.2017.02.007
doi: 10.1016/j.jneuroim.2017.02.007
pubmed: 28284340
López-Valverde N, López-Valverde A, Gómez de Diego R, Cieza-Borrella C, Ramírez JM, González-Sarmiento R (2019) Genetic study in patients operated dentally and anesthetized with articaine-epinephrine. J Pain Res 12:1371–1384. https://doi.org/10.2147/JPR.S193745
doi: 10.2147/JPR.S193745
pubmed: 31118755
pmcid: 6499144
Kalfon L, Azran A, Farajun Y, Golan-Hamu O, Toben A, Abramov L, Yeshaya A, Yakir O, Zarfati D, Falik Zaccai TC, Bornstein J (2019) Localized provoked Vulvodynia: Association with nerve growth factor and transient receptor potential vanilloid type 1 genes polymorphisms. J Low Genit Tract Dis 23:58–64. https://doi.org/10.1097/LGT.0000000000000445
doi: 10.1097/LGT.0000000000000445
pubmed: 30418350
Cargnin S, Viana M, Mittino D, Bellomo G, Tassorelli C, Nappi G, Canonico PL, Terrazzino S (2014) Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans. Neurol Sci 35:421–427. https://doi.org/10.1007/s10072-013-1535-1
doi: 10.1007/s10072-013-1535-1
pubmed: 24030684
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716. https://doi.org/10.1046/j.1445-2197.2003.02748.x
doi: 10.1046/j.1445-2197.2003.02748.x
pubmed: 12956787
Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1:97–111. https://doi.org/10.1002/jrsm.12
doi: 10.1002/jrsm.12
pubmed: 26061376
Ishibashi M, Kasai H, Katoh H, Ishii M (2018) Lack of association between TRP Gene Polymorphisms and complication of Medication Overuse Headache in Migraine patients. J Med - Clin Res Reviews 2:1–5. https://doi.org/10.33425/2639-944X.1047
doi: 10.33425/2639-944X.1047
Chalmer MA, Rasmussen AH, International Headache Genetics Consortium; 23andme Research Team, Kogelman LJA, Olesen J, Hansen TF (2021) Chronic migraine: Genetics or environment? Eur J Neurol 28(5):1726–1736. https://doi.org/10.1111/ene.14724
doi: 10.1111/ene.14724
pubmed: 33428804
Benemei S, Dussor G (2019) TRP channels and migraine: recent developments and New Therapeutic opportunities. Pharmaceuticals (Basel) 12:54. https://doi.org/10.3390/ph12020054
doi: 10.3390/ph12020054
pubmed: 30970581
Shibata M, Tang C (2021) Implications of transient receptor potential cation channels in Migraine Pathophysiology. Neurosci Bull 37:103–116. https://doi.org/10.1007/s12264-020-00569-5
doi: 10.1007/s12264-020-00569-5
pubmed: 32870468
Quartu M, Serra MP, Boi M, Poddighe L, Picci C, Demontis R, Del Fiacco M (2016) TRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP. J Anat 229:755–767. https://doi.org/10.1111/joa.12529
doi: 10.1111/joa.12529
pubmed: 27456865
pmcid: 5108161
Hou M, Uddman R, Tajti J, Kanje M, Edvinsson L (2002) Capsaicin receptor immunoreactivity in the human trigeminal ganglion. Neurosci Lett 330:223–226. https://doi.org/10.1016/s0304-3940(02)00741-3
doi: 10.1016/s0304-3940(02)00741-3
pubmed: 12270633
Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139:1405–1415. https://doi.org/10.1016/j.neuroscience.2006.02.074
doi: 10.1016/j.neuroscience.2006.02.074
pubmed: 16603318
Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009;8:679–690. https://doi.org/10.1016/S1474-4422(09)70090-0
Dux M, Sántha P, Jancsó G (2003) Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol 552(Pt 3):859–867. https://doi.org/10.1113/jphysiol.2003.050633
doi: 10.1113/jphysiol.2003.050633
pubmed: 12949222
pmcid: 2343470
Bernardini N, Neuhuber W, Reeh PW, Sauer SK (2004) Morphological evidence for functional capsaicin receptor expression and calcitonin gene-related peptide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience 126:585–590. https://doi.org/10.1016/j.neuroscience.2004.03.017
doi: 10.1016/j.neuroscience.2004.03.017
pubmed: 15183508
Iwashita T, Shimizu T, Shibata M, Toriumi H, Ebine T, Funakubo M, Suzuki N (2013) Activation of extracellular signal-regulated kinase in the trigeminal ganglion following both treatment of the dura mater with capsaicin and cortical spreading depression. Neurosci Res 77:110–119. https://doi.org/10.1016/j.neures.2013.08.001
doi: 10.1016/j.neures.2013.08.001
pubmed: 23962823
Del Fiacco M, Quartu M, Boi M, Serra MP, Melis T, Boccaletti R, Shevel E, Cianchetti C (2015) TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine. J Neurol Neurosurg Psychiatry 86:393–397. https://doi.org/10.1136/jnnp-2014-308813
doi: 10.1136/jnnp-2014-308813
pubmed: 25288608
Buonvicino D, Urru M, Muzzi M, Ranieri G, Luceri C, Oteri C, Lapucci A, Chiarugi A (2018) Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns. Pain 159:1980–1988. https://doi.org/10.1097/j.pain.0000000000001291
doi: 10.1097/j.pain.0000000000001291
pubmed: 29794878